Top Gene editing companies by Employees
In this list you can find who is the biggest employer in the Gene editing. Based on the financial data of 19 Gene editing stocks. In 2024 public companies employ 47.98K people.
20 Nov 2024, 12:52 UTC
Companies: 19
🇺🇸1 |  | $1,162.00 | 2.04% | 12.46K | 32.97% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸2 |  | $130.97 | 0.58% | 11.50K | -5.02% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸3 |  | $197.53 | -0.34% | 8.72K | -23.31% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳4 |  | $1.56 | 2.19% | 6.41K | -38.81% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸5 |  | $474.16 | -1.48% | 4.80K | 17.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇳6 |  | $3.17 | 5.49% | 755.00 | -41.33% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸7 |  | $22.52 | -0.13% | 598.00 | -25.06% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸8 |  | $0.91 | 7.92% | 478.00 | 67.87% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇨🇭9 |  | $49.59 | -0.56% | 458.00 | -19.81% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸10 |  | $25.50 | -0.31% | 439.00 | -5.38% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸11 |  | $0.49 | -1.02% | 323.00 | -63.88% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸12 |  | $3.87 | 1.04% | 226.00 | -61.30% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸13 |  | $5.51 | 2.23% | 204.00 | -60.13% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸14 |  | $4.10 | 2.89% | 175.00 | -53.62% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸15 |  | $36.73 | -1.45% | 95.00 | -22.08% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵16 |  | $0.87 | 0.00% | 92.00 | -27.91% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇺🇸17 |  | $7.14 | -3.25% | 87.00 | 19.00% | Outperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇰🇷18 |  | $43.79 | 6.84% | 83.00 | -16.95% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
🇯🇵19 |  | $3.20 | -0.66% | 65.00 | -2.36% | Underperform S&P500 YTD Benchamark | 🧬 Biotech | - |
